메뉴 건너뛰기




Volumn 21, Issue 5, 2006, Pages 1439-1440

Reversible paraparesis in multiple myeloma with renal failure

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; MELPHALAN; PREDNISONE; THALIDOMIDE; VINCRISTINE;

EID: 33646176453     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl086     Document Type: Article
Times cited : (4)

References (5)
  • 1
    • 0035880229 scopus 로고    scopus 로고
    • Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: Identification of prognostic factors in a phase 2 study of 169 patients
    • Barlogie B, Desikan R, Eddlemon P et al. Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients. Blood 2001; 98: 492-494
    • (2001) Blood , vol.98 , pp. 492-494
    • Barlogie, B.1    Desikan, R.2    Eddlemon, P.3
  • 2
    • 0038007193 scopus 로고    scopus 로고
    • Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia
    • Harris E, Behrens J, Samson D, Rahemtulla A, Russell NH, Byrne JL. Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia. Br J Haematol 2003; 122: 160-161
    • (2003) Br J Haematol , vol.122 , pp. 160-161
    • Harris, E.1    Behrens, J.2    Samson, D.3    Rahemtulla, A.4    Russell, N.H.5    Byrne, J.L.6
  • 3
    • 1842610155 scopus 로고    scopus 로고
    • Thalidomide in patients with multiple myeloma and renal failure
    • Fakhouri F, Guerraoui H, Presne C et al. Thalidomide in patients with multiple myeloma and renal failure. Br J Haematol 2004; 125: 96-97
    • (2004) Br J Haematol , vol.125 , pp. 96-97
    • Fakhouri, F.1    Guerraoui, H.2    Presne, C.3
  • 4
    • 0037089681 scopus 로고    scopus 로고
    • Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma
    • Cany L, Fitoussi O, Boiron JM, Marit G. Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma. J Clin Oncol 2002; 20: 2212
    • (2002) J Clin Oncol , vol.20 , pp. 2212
    • Cany, L.1    Fitoussi, O.2    Boiron, J.M.3    Marit, G.4
  • 5
    • 0028363339 scopus 로고
    • Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial
    • Silva SR, Viana PC, Lugon NV, Hoette M, Ruzany F, lugon JR. Thalidomide for the treatment of uremic pruritus: A crossover randomized double-blind trial. Nephron 1994; 67: 270-273
    • (1994) Nephron , vol.67 , pp. 270-273
    • Silva, S.R.1    Viana, P.C.2    Lugon, N.V.3    Hoette, M.4    Ruzany, F.5    Lugon, J.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.